PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1795934

Pharmaceuticals and developing countries: problems and prospects.

D C Jayasuriya
View original source ↗Export metadata ↓

Abstract

For many decades there was little consensus on the nature and type of pharmaceutical policies best suited for developing countries. In the aftermath of the Nairobi Conference on the Rational Use of Drugs and the formulation of criteria by expert groups convened by the World Health Organization a consensus has emerged on many aspects. Infrastructure development and the deployment of trained manpower are now perceived as two of the essential requisites for the implementation of national pharmaceutical policies. The article reviews selected problem areas in the pharmaceuticals sector and proposes strategies to overcome them.

Explore related subjects

Developing CountriesDrug TherapyPharmaceutical PreparationsWorld Health OrganizationJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D C Jayasuriya. 1991-12-13. Pharmaceuticals and developing countries: problems and prospects.. https://doi.org/10.1007/bf02015578

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Costs of surgeries in low- and middle-income countries: a systematic literature review.

BACKGROUND: Surgical care is essential for achieving global health equity, yet low- and middle-income countries (LMICs) face major gaps in access and planning, partly due to limited evidence on the costs and resource requirements of surgical interventions. Understanding these costs is vital for designing efficient and equitable health systems. METHODS: We conducted a systematic literature review (covering MEDLINE, EMBASE, Global Health, EconLit and grey literature) to identify studies reporting the costs of surgeries in LMICs from January 2000 to June 2023. Minor and major surgical procedures were considered, focusing on therapeutic procedures (excluding diagnostic interventions). Studies that clearly identified, quantified and costed hospital resources and services deployed in the provision of surgical care, and included at least two of the surgical production factors (ie, consumables, diagnostics, personnel, infrastructure and overhead) in the costing were included. Costs were standardised to 2023 International dollars (I$) for comparability. RESULTS: A total of 74 studies from 29 countries met the inclusion criteria, with 210 cost estimates across 65 procedure groups. Costs varied widely: from I$1.54 for a caesarean section in Tanzania to I$618 098 for paediatric cataract surgery in Zambia. Full costing studies reported higher estimates than partial costing studies. Most studies (60%) originated from upper-middle-income countries, with limited data (10%) from low-income settings. CONCLUSION: This review provides a reference list of surgical procedure costs across LMICs, highlighting considerable cost variation by procedure, specialty and country. The findings underscore the need for better-quality, standardised cost data-especially from low-income countries-to inform national surgical plans, universal health coverage benefit packages and reimbursement policies.

Developing Countries↗